Nephrotic Syndrome - 19/11/18
, Larry A. Greenbaum, MD, PhDRésumé |
Nephrotic syndrome is characterized by edema, proteinuria, hypoalbuminemia, and hyperlipidemia. Minimal change disease, the most common cause in childhood, generally responds to corticosteroids, although most patients experience disease relapses. Focal segmental glomerulosclerosis is usually resistant to corticosteroids and carries a significant risk of kidney failure, necessitating renal transplantation. Nephrotic syndrome may also be secondary to gene mutations and systemic diseases such as lupus. Clinical evaluation involves distinguishing primary and secondary causes and monitoring for disease complications, including blood clots and serious infections such as spontaneous bacterial peritonitis. Immunosuppressive medications are used to prevent relapses and treat corticosteroid-resistant disease.
Le texte complet de cet article est disponible en PDF.Keywords : Nephrotic syndrome, Edema, Peritonitis, Thrombosis, Minimal change disease, Focal segmental glomerulosclerosis
Plan
| Disclosure: C. Wang and L.A. Greenbaum have received funding from Mallinckrodt Pharmaceuticals for an investigator-initiated clinical trial of H.P. Acthar Gel in childhood nephrotic syndrome. L.A. Greenbaum serves on the Data and Safety Monitoring Board for a clinical trial sponsored by Retrophin in patients with nephrotic syndrome. L.A. Greenbaum is a co-investigator of CureGN, an observational study of nephrotic syndrome patients sponsored by the National Institutes of Health. |
Vol 66 - N° 1
P. 73-85 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
